Mesoblast Files Request for Type B Meeting with FDA to Discuss Accelerated Approval Pathway for Revascor® in Ischemic Heart Failure
Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on its plans to meet with the United States Food and Drug ...
I’m a Harvard-educated doctor — this bad nightly habit can increase your risk of heart disease
Experts recommend brushing at least twice a day and flossing once a day to eliminate plaque-forming bacteria that could ...
Medscape16h
Antidepressants Linked to Sudden Cardiac Death Risk, Early Results Suggest
Use of antidepressants for 6 or more years is linked to an increased risk for sudden cardiac death, but it’s unclear if the ...
healthdigest.com on MSN1d
You Might Have Heart Disease If This Happens To Your Eyes
Cardiologists aren't the only doctors who can detect heart disease. Eye doctors may also be able to spot it if this change ...
New drug cuts down genetically inherited heart disease risk factor
“Nearly a quarter of the world’s population has elevated levels of Lp (a), putting them at a significantly higher risk of cardiovascular events such as heart attacks and strokes,” said Steven Nissen, ...
ACC 25: Biocardia’s CardiAMP trial fails but cell therapy potential remains
The therapeutic approach was safe, but the study did not meet its primary efficacy outcome using the six-minute walking test.
Healio6d
FDA recap: First new treatment for stroke in 3 decades, generic rivaroxaban and more
The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...